Neglected sulfur( vi ) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development
Year: 2019
Type: article
Abstract: The key learnings of the utilization of sulfoximines, sulfondiimines and sulfonimidamides in drug discovery at Bayer AG are shared.
Source: Organic Chemistry Frontiers
DOI: 10.1039/c8qo01233d
Author: U. Lücking
Institutions: Drug Discovery Laboratory (Norway), Bayer (Germany)
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: hybrid
Funders: Bayer, University of Nottingham
OpenAlex ID: W2940292178
